MGRX
Another MOU, another nuclear plot twist
Mangoceuticals, better known by its ticker MGRX, is back with more merger-partner news. This time, Nuclea Energy — the advanced nuclear company sitting inside Mangoceuticals’ orbit — signed a non-binding memorandum of understanding with New Mining Co. to kick the tires on modular reactor deployment for high-density computing infrastructure.
That’s a mouthful, but the gist is simple: can Nuclea’s reactor tech help power data-center-style operations behind the meter, instead of relying entirely on the grid? The companies want to test the technical and structural feasibility of building toward a cumulative 100 MWe of capacity.
Why investors should care
This isn’t a signed buildout or a revenue lock. It’s more like the corporate version of saying, “let’s see if we’d be good roommates before signing the lease.” Still, these kinds of MOUs matter because they keep the commercial story alive and give the market another breadcrumb trail for how Nuclea could turn its technology into actual projects.
For Mangoceuticals holders, the takeaway is less about boxed-up reactor hardware and more about optionality. If Nuclea keeps landing these partnership discussions, the merger narrative looks a lot less like a science fair project and a lot more like a business plan.
Big picture: MGRX is trying to hitch its wagon to the nuclear-for-data-centers theme, and the market tends to reward anything that smells like a credible path from futuristic pitch deck to actual watts.